Search Within

Salomon Tendler

Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
  3. Editorial (1)
  4. Review (1)
Groups
  1. GME, Medicine (8)
  2. Graduate Medical Education (8)
  3. Sloan Kettering Institute Postdocs (8)
  4. Department of Medicine (7)
  5. Solid Tumor Oncology Division (7)
  6. Thoracic Oncology (7)

More Groups

People
  1. Charles Rudin (6)
  2. Jason Lewis (5)
  3. Joshua Korsen (3)
  4. Lukas Carter (3)
  5. Nagavarakishore Pillarsetty (3)
  6. Alexa Michel (2)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Journal of Thoracic Oncology (2)
  3. CTS-Clinical and Translational Science (1)
  4. Clinical Cancer Research (1)
  5. Lancet Oncology (1)
  6. Nature Reviews Clinical Oncology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Elsevier Inc. (2)
  3. American Association for Cancer Research (1)
  4. Elsevier Science, Inc. (1)
  5. Nature Publishing Group (1)
  6. Wiley Blackwell (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emerging importance of HER3 in tumorigenesis and cancer therapy
    Review

    Garrett, J. T.; Tendler, S.; Feroz, W.; Kilroy, M. K.; Yu, H.
    Nature Reviews Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Exploring the discrepancies between clinical trials and real-world data: A small-cell lung cancer study
    Journal Article

    Marzano, L.; Darwich, A. S.; Dan, A.; Tendler, S.; Lewensohn, R.; De Petris, L.; Raghothama, J.; Meijer, S.
    CTS-Clinical and Translational Science (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Radiotheranostics targeting Delta-like ligand 3 expressing small-cell lung cancers
    Meeting Abstract

    Tendler, S.; Hoang, T.; Bauer, D.; Korsen, J.; Carter, L.; Michel, A.; Degregorio, R.; Pillarsetty, N.; Poirier, J. T.; Lewis, J. S.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • A theranostic approach: Imaging and therapy of delta-like ligand 3–expressing small cell lung cancers
    Meeting Abstract

    Tendler, S.; Hoang, T. T.; Bauer, D.; Korsen, J.; Michel, A.; Degregorio, R.; Carter, L.; Pillarsetty, N.; Poirier, J. T.; Lewis, J. S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Tarlatamab: New star on the horizon for small-cell lung cancer?
    Editorial

    Tendler, S.; Rudin, C. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Radioimmunotherapy targeting Delta-like ligand 3 in small cell lung cancer exhibits antitumor efficacy with low toxicity
    Journal Article

    Tully, K. M.; Tendler, S.; Carter, L. M.; Sharma, S. K.; Samuels, Z. V.; Mandleywala, K.; Korsen, J. A.; Reyes, A. M. D.; Piersigilli, A.; Travis, W. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save